Movement Disorders (revue) - Analysis (France)

Index « Auteurs » - entrée « Olivier Rascol »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Olivier Nicole < Olivier Rascol < Olivier Toulza  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 92.
[20-40] [0 - 20][0 - 50][40-60]
Ident.Authors (with country if any)Title
000198 (2010) Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne]Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study
000199 (2010) Anthony H. V. Schapira [Royaume-Uni] ; Stefan Albrecht [Allemagne] ; Paolo Barone [Italie] ; Cynthia L. Comella [États-Unis] ; Michael P. Mcdermott [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Kenneth Marek [États-Unis]Rationale for delayed‐start study of pramipexole in Parkinson's disease: The PROUD study
000200 (2010) Robert A. Hauser [États-Unis] ; Anthony H. V. Schapira [Royaume-Uni] ; Olivier Rascol [France] ; Paolo Barone [Italie] ; Yoshikuni Mizuno [Japon] ; Laurence Salin [France] ; Monika Haaksma [Autriche] ; Nolwenn Juhel [France] ; Werner Poewe [Autriche]Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease
000202 (2010) Martin Köllensperger [Autriche] ; Felix Geser [Autriche] ; Jean-Pierre Ndayisaba [Autriche] ; Sylvia Boesch [Autriche] ; Klaus Seppi [Autriche] ; Karen Ostergaard [Danemark] ; Erik Dupont [Danemark] ; A. Cardozo [Espagne] ; Eduardo Tolosa [Espagne] ; Michael Abele [Allemagne] ; Thomas Klockgether [Allemagne] ; Farid Yekhlef [France] ; Francois Tison [France] ; Christine Daniels [Allemagne] ; Günther Deuschl [Allemagne] ; Miguel Coelho [Portugal] ; Cristina Sampaio [Portugal] ; Maria Bozi [Royaume-Uni] ; Niall Quinn [Royaume-Uni] ; Anette Schrag [Royaume-Uni] ; Chris J. Mathias [Royaume-Uni] ; Clare Fowler [Royaume-Uni] ; Christer F. Nilsson [Suède] ; H Kan Widner [Suède] ; Nicole Schimke [Allemagne] ; Wolfgang Oertel [Allemagne] ; Francesca Del Sorbo [Italie] ; Alberto Albanese [Italie] ; Maria Teresa Pellecchia [Italie] ; Paolo Barone [Italie] ; Ruth Djaldetti [Israël] ; Carlo Colosimo [Italie] ; Giuseppe Meco [Italie] ; Antonio Gonzalez-Mandly [Espagne] ; Jose Berciano [Espagne] ; Tanya Gurevich [Israël] ; Nir Giladi [Israël] ; Monique Galitzky [France] ; Olivier Rascol [France] ; Christoph Kamm [Allemagne] ; Thomas Gasser [Allemagne] ; Uwe Siebert [Autriche, États-Unis] ; Werner Poewe [Autriche] ; Gregor K. Wenning [Autriche]Presentation, diagnosis, and management of multiple system atrophy in Europe: Final analysis of the European multiple system atrophy registry
000206 (2010) Olivier Rascol [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France] ; Anne-Marie Bonnet [France] ; Christine Brefel-Courbon [France] ; Pierre Césaro [France] ; Philippe Damier [France] ; Bérengère Debilly [France] ; Frank Durif [France] ; Monique Galitzky [France] ; Jean-Marie Grouin [France] ; Sylvie Pennaforte [France] ; Gabriel Villafane [France] ; Sadek Yaici [France] ; Yves Agid [France]Orodispersible sublingual piribedil to abort OFF episodes: A single dose placebo‐controlled, randomized, double‐blind, cross‐over study
000216 (2010) Joseph H. Friedman [États-Unis] ; Guido Alves [Norvège] ; Peter Hagell [Suède] ; Johan Marinus [Pays-Bas] ; Laura Marsh [États-Unis] ; Pablo Martinez-Martin [Espagne] ; Christopher G. Goetz [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn Stebbins [États-Unis] ; Anette Schrag [Royaume-Uni]Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease
000217 (2010) Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France]Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease
000219 (2010) Juliana Bronzova [Pays-Bas] ; Cristina Sampaio [Portugal] ; Robert A. Hauser [États-Unis] ; Anthony E. Lang [Canada] ; Olivier Rascol [France] ; Ad Theeuwes [Pays-Bas] ; Serge V. Van De Witte [Pays-Bas] ; Guus Van Scharrenburg [Pays-Bas]Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease
000222 (2010) Laurence Nègre-Pagès [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lépine [France] ; Olivier Rascol [France]Anxious and depressive symptoms in Parkinson's disease: The French cross‐sectionnal DoPaMiP study
000223 (2010) Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse drug reactions to dopamine agonists: A comparative study in the french pharmacovigilance database
000228 (2010) Laurence Negre-Pages [France] ; Hélène Grandjean [France] ; Maryse Lapeyre-Mestre [France] ; Jean Louis Montastruc [France] ; Annie Fourrier [France] ; Jean Pierre Lepine [France] ; Olivier Rascol [France]Anxious and Depressive Symptoms in Parkinson's Disease: The French Cross-Sectionnal DoPAMiP Study
000229 (2010) Santiago Perez-Lloret [France] ; Emmanuelle Bondon-Guitton [France] ; Olivier Rascol [France] ; Jean-Louis Montastruc [France]Adverse Drug Reactions to Dopamine Agonists: A Comparative Study in the French Pharmacovigilance Database
000231 (2009) Nir Giladi [Israël] ; Joseph Tal [Israël] ; Tali Azulay [Israël] ; Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Eldad Melamed [Israël] ; Wolfgang Oertel [Allemagne] ; Werner Poewe [Autriche] ; Fabrizio Stocchi [Italie] ; Eduardo Tolosa [Espagne]Validation of the freezing of gait questionnaire in patients with Parkinson's disease
000256 (2009) Marian L. Evatt [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; Kelvin L. Chou [États-Unis] ; Ester Cubo [Espagne] ; Vanessa Hinson [États-Unis] ; Katie Kompoliti [États-Unis] ; Chengwu Yang [États-Unis] ; Werner Poewe [États-Unis] ; Olivier Rascol [Autriche] ; Cristina Sampaio [France, Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Dysautonomia rating scales in Parkinson's disease: Sialorrhea, dysphagia, and constipation—Critique and recommendations by movement disorders task force on rating scales for Parkinson's disease
000262 (2009) Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Sabrina Debruxelles [France] ; Igor Sibon [France] ; Cyril Goizet [France] ; Pierre Labauge [France] ; Patrice Menegon [France] ; Emmanuelle Uro-Coste [France] ; Bernardino Ghetti [États-Unis] ; Marie Bernadetle Delisle [France] ; Ruben Vidal [États-Unis] ; Olivier Rascol [France]Clinical phenotype and neuroimaging findings in a French family with hereditary ferritinopathy (FTL498‐499InsTC)
000267 (2009) Donald Grosset [Royaume-Uni] ; Angelo Antonini [Italie] ; Margherita Canesi [Italie] ; Gianni Pezzoli [Italie] ; Andrew Lees (neurologue) [Royaume-Uni] ; Karen Shaw [Royaume-Uni] ; Esther Cubo [Espagne] ; Pablo Martinez-Martin [Espagne] ; Olivier Rascol [France] ; Laurence Negre-Pages [France] ; Ana Senard [France] ; Johannes Schwarz [Allemagne] ; Karl Strecker [Allemagne] ; Heinz Reichmann [Allemagne] ; Alexander Storch [Allemagne] ; Matthias Löhle [Allemagne] ; Fabrizio Stocchi [Italie] ; Katherine Grosset [Royaume-Uni]Adherence to antiparkinson medication in a multicenter European study
000268 (2009) Olivier Rascol [France] ; Ludwig Schelosky [Suisse]123I‐metaiodobenzylguanidine scintigraphy in Parkinson's disease and related disorders
000270 (2009) Fabienne Ory-Magne [France] ; Christine Brefel-Courbon [France] ; Pierre Payoux [France] ; Sabrina Debruxelles [France] ; Igor Sibon [France] ; Cyril Goizet [France] ; Pierre Labauge [France] ; Patrice Menegon [France] ; Emmanuelle Uro-Coste [France] ; Bernardino Ghetti [États-Unis] ; Marie Bernadetle Delisle [France] ; Ruben Vidal [États-Unis] ; Olivier Rascol [France]Clinical Phenotype and Neuroimaging Findings in a French Family with Hereditary Ferritinopathy (FTL498-499InsTC)
000271 (2009) Olivier Rascol [France] ; Ludwig Schelosky [Suisse]123I-Metaiodobenzylguanidine Scintigraphy in Parkinson's Disease and Related Disorders
000280 (2008) Hubert H. Fernandez [États-Unis] ; Dag Aarsland [Norvège] ; Gilles Fénelon [France] ; Joseph H. Friedman [États-Unis] ; Laura Marsh [États-Unis] ; Alexander I. Tröster [États-Unis] ; Werner Poewe [Autriche] ; Olivier Rascol [France] ; Cristina Sampaio [Portugal] ; Glenn T. Stebbins [États-Unis] ; Christopher G. Goetz [États-Unis]Scales to assess psychosis in Parkinson's disease: Critique and recommendations
000285 (2008) Christopher G. Goetz [États-Unis] ; Eugene Laska [États-Unis] ; Christine Hicking [Allemagne] ; Philippe Damier [France] ; Thomas Müller [Allemagne] ; John Nutt [États-Unis] ; C. Warren Olanow [États-Unis] ; Olivier Rascol [France] ; Hermann Russ [Allemagne]Placebo influences on dyskinesia in Parkinson's disease

List of associated KwdEn.i

Nombre de
documents
Descripteur
70Humans
57Parkinson disease
53Nervous system diseases
47Parkinson's disease
39Female
38Male
36Parkinson Disease (drug therapy)
34Middle Aged
29Aged
27Severity of Illness Index
22Antiparkinson Agents (therapeutic use)
21Treatment
20Human
18Antiparkinson Agents (adverse effects)
18Double-Blind Method
17Adult
16Parkinson Disease (physiopathology)
16Treatment Outcome
14Dose-Response Relationship, Drug
13Levodopa
13Questionnaires
12Antiparkinson Agents (administration & dosage)
11Dopamine agonist
11Levodopa (adverse effects)
11Levodopa (therapeutic use)
11Parkinson Disease (complications)
11Parkinson Disease (diagnosis)
11Recommendation
11rating scales
10Reproducibility of Results
9Antiparkinson agent
9Chemotherapy
9levodopa
8Double blind study
8Drug Therapy, Combination
8Multiple system atrophy
8Psychometrics
8clinimetrics
7Drug Administration Schedule
7Dyskinesia
7Follow-Up Studies
7Parkinson Disease (psychology)
7Placebo
7Ropinirole
6Agonist
6Disability Evaluation
6Parkinson Disease (epidemiology)
6Quality of Life
6Safety
6Time Factors
5Aged, 80 and over
5Bromocriptine
5Dopamine Agonists (adverse effects)
5Dyskinesia, Drug-Induced (etiology)
5Force
5Indoles (therapeutic use)
5Levodopa (administration & dosage)
5Parkinson Disease (therapy)
5Pramipexole
5Reliability
5dopamine agonists
5dyskinesia
4Amine oxidase (flavin-containing)
4Bromocriptine (therapeutic use)
4Clinical trial
4Comparative study
4Confidence Intervals
4Cross-Over Studies
4Deep brain stimulation
4Depression
4Evaluation scale
4France
4France (epidemiology)
4French
4Odds Ratio
4Pilot Projects
4Piribedil
4Prospective Studies
4Risk Factors
4Validity
4deep brain stimulation
4depression
4dopamine agonist
4multiple system atrophy
4psychometrics
4reliability
4validity
3Age Factors
3Age of Onset
3Amantadine (therapeutic use)
3Benzothiazoles
3Benzothiazoles (administration & dosage)
3Deep Brain Stimulation (methods)
3Disease Progression
3Diseases of the autonomic nervous system
3Dopamine Agonists (therapeutic use)
3Dopamine receptor
3Early
3Evaluation Studies as Topic
3Evidence-based medicine

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/France/Analysis
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i -k "Olivier Rascol" 
HfdIndexSelect -h $EXPLOR_AREA/Data/France/Analysis/Author.i  \
                -Sk "Olivier Rascol" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/France/Analysis/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    France
   |étape=   Analysis
   |type=    indexItem
   |index=    Author.i
   |clé=    Olivier Rascol
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024